Denk Pharma GmbH & Co. KG

denkpharma.de

DENK PHARMA is a global company with core competence in the area of health care. DENK PHARMA was founded in Munich, Germany in 1948. We have a strong focus on export markets and presently supply our DENK PHARMA premium medicine and food supplements around the world. For more than 70 years, we have delivered quality that is “Made in Germany” – we manufacture, quality control and register all of our products in Germany. This enables us to ensure that all patients worldwide receive the same high-quality as they do in Germany.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

BOSTON SCIENTIFIC ANNOUNCES PARTNERSHIP DEFINITIVE AGREEMENT TO DIVEST BTG SPECIALTY PHARMACEUTICALS BUSINESS

Boston Scientific | December 02, 2020

news image

Boston Scientific Corporation today declared that it has gone into a conclusive concurrence with Stark International Lux S.A.R.L., and SERB SAS, partners of SERB, an European strength drug gathering, to sell its BTG Specialty Pharmaceuticals business for $800 million in real money. SERB, supported by private value firm Charterhouse Capital Partners since 2017, possesses an expanded arrangement of doctor prescribed prescriptions zeroed in on uncommon and hazardous infections. "...

Read More

Business Insights, PHARMACY MARKET

AQUESTIVE THERAPEUTICS EXPANDS LICENSE AND SUPPLY AGREEMENT WITH PHARMANOVIA FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM TO ADDITIONAL GLOBAL MARKETS

Globenewswire | March 30, 2023

news image

Aquestive Therapeutics, Inc. a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, today announced it has expanded its exclusive license and supply agreement with Atnahs Pharma UK Limited (“Pharmanovia”), a global pharmaceutical company that revitalizes, extends and expands the lifecycle of established medicines, for Libervant™ Buccal Film to cover the rest ...

Read More

GILEAD CLIMBS AS CORONAVIRUS DRUG SHOWS EFFICACY, STARTS TRIAL

FierceBiotech | February 03, 2020

news image

Gilead has made progress in its effort to reposition failed Ebola drug remdesivir as a treatment for the coronavirus sweeping across China. In quick succession, it emerged that the nucleotide analogue prodrug appeared to help the first U.S. case of the virus and is set to undergo clinical testing in China, sending Gilead’s stock up by as much as 13% in premarket trading. Remdesivir was one of a clutch of drugs tested against Ebola, but it failed to match the efficacy of its rivals, leading...

Read More

PHARMACY MARKET, PHARMA TECH

FORCURA SIGNS CSI PHARMACY, MARKING ENTRY INTO HOME INFUSION MARKET

Businesswire | June 22, 2023

news image

Forcura, a healthcare workflow management company, announced that CSI Pharmacy, a nationally accredited specialty pharmacy that provides infusion therapy services, will adopt Forcura’s cloud-based technology to enhance patient onboarding, care plan management and care coordination. This agreement officially ushers Forcura into the home infusion market expanding their scope of practice to include another vertical of home-based care. Through Forcura, CSI Pharmacy will gradua...

Read More
news image

Pharmacy Market

BOSTON SCIENTIFIC ANNOUNCES PARTNERSHIP DEFINITIVE AGREEMENT TO DIVEST BTG SPECIALTY PHARMACEUTICALS BUSINESS

Boston Scientific | December 02, 2020

Boston Scientific Corporation today declared that it has gone into a conclusive concurrence with Stark International Lux S.A.R.L., and SERB SAS, partners of SERB, an European strength drug gathering, to sell its BTG Specialty Pharmaceuticals business for $800 million in real money. SERB, supported by private value firm Charterhouse Capital Partners since 2017, possesses an expanded arrangement of doctor prescribed prescriptions zeroed in on uncommon and hazardous infections. "...

Read More
news image

Business Insights, PHARMACY MARKET

AQUESTIVE THERAPEUTICS EXPANDS LICENSE AND SUPPLY AGREEMENT WITH PHARMANOVIA FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM TO ADDITIONAL GLOBAL MARKETS

Globenewswire | March 30, 2023

Aquestive Therapeutics, Inc. a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, today announced it has expanded its exclusive license and supply agreement with Atnahs Pharma UK Limited (“Pharmanovia”), a global pharmaceutical company that revitalizes, extends and expands the lifecycle of established medicines, for Libervant™ Buccal Film to cover the rest ...

Read More
news image

GILEAD CLIMBS AS CORONAVIRUS DRUG SHOWS EFFICACY, STARTS TRIAL

FierceBiotech | February 03, 2020

Gilead has made progress in its effort to reposition failed Ebola drug remdesivir as a treatment for the coronavirus sweeping across China. In quick succession, it emerged that the nucleotide analogue prodrug appeared to help the first U.S. case of the virus and is set to undergo clinical testing in China, sending Gilead’s stock up by as much as 13% in premarket trading. Remdesivir was one of a clutch of drugs tested against Ebola, but it failed to match the efficacy of its rivals, leading...

Read More
news image

PHARMACY MARKET, PHARMA TECH

FORCURA SIGNS CSI PHARMACY, MARKING ENTRY INTO HOME INFUSION MARKET

Businesswire | June 22, 2023

Forcura, a healthcare workflow management company, announced that CSI Pharmacy, a nationally accredited specialty pharmacy that provides infusion therapy services, will adopt Forcura’s cloud-based technology to enhance patient onboarding, care plan management and care coordination. This agreement officially ushers Forcura into the home infusion market expanding their scope of practice to include another vertical of home-based care. Through Forcura, CSI Pharmacy will gradua...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us